2025 Dry Eye Pharmaceuticals Market Report: Global Analysis for 2024 to 2030, December, 2025

The “2025 Dry Eye Pharmaceuticals Market Report” evaluates the evolving market for prescription and over-the-counter therapies used in the management of dry eye disease. The report combines epidemiological data, disease characterization, and five-year market projections to outline future opportunities in one of ophthalmology’s fastest-growing categories. 

The following topics are covered in the report: 

• Comprehensive overview of dry eye disease: anatomy of normal tear function, symptoms, risk factors, diagnostic criteria, and DEWS classification 
• Prevalence and risk analysis: regional estimates and risk profiles for the US, Western Europe, Japan, China, India, Latin America, and other global markets 
• Diagnosis and care trends: approaches to diagnosis, regional practice variations, and severity segmentation 
• Treatment pathways and product segmentation: analysis of lubricants, anti-inflammatories, and sustained-release therapeutics 
• Global and regional market forecasts: unit demand, revenue forecasts, market share by product type and company, and consumption trends through 2030 
• Pharmaceutical pipeline analysis: detailed review of more than 30 investigational compounds and emerging drug-delivery technologies 
• Profiles of major competitors: in-depth profiles of 23 leading dry eye pharmaceutical manufacturers, including their portfolios, strategies, and outlook 

2 licensing types are available for this report:

• The price of the single-user license is $7,350.
• The price of the enterprise license is $11,025 (includes supplemental Excel file with all the tables and figures in the report, and report summary slides).

Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.

SINGLE USER LICENSE

• The Single User License allows for the use of a report by a single user within one corporate location.
• The report paper copy may not be reproduced (additional paper copies available for purchase).
• Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
• Only a single copy of the publication may be printed for internal use.
• Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

• The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
• Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
• Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Purchase price includes a printable PDF file of the report (purchasing organization may print multiple copies for use within the organization).
• Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.

Pay by credit card or by invoice.